Health, Pharma & Biotech Startup Grants and Funding Programs in India — September 2026

As of September 2026, eight active funding and support programs are available for Health, Pharma & Biotech startups in India. These opportunities encompass a mix of grants, incubation programs, and innovation competitions designed to foster growth in the sector.

The Indian Health, Pharma & Biotech funding landscape features initiatives from government bodies, established incubators, and venture capital firms. These programs collectively aim to support startups from early-stage concept development through to market commercialization, addressing important needs in innovation and intellectual property protection.

Active Health, Pharma & Biotech Grants and Programs

Patent Reimbursement Incentives: Karnataka Startup Policy (KBITS, Government of Karnataka)

The Patent Reimbursement Incentives: Karnataka Startup Policy offers financial support for incubated startups officially registered with the Karnataka Startup Cell. This program is managed by the Karnataka Biotechnology and Information Technology Services (KBITS), an agency under the Government of Karnataka, which focuses on developing the state's technology and startup ecosystem.

The policy's goal is to alleviate the financial expenditures associated with securing intellectual property rights. Eligible startups must be incubated and registered with the Karnataka Startup Cell. The incentive provides up to ₹10,00,000, supporting technology-driven ventures in Karnataka, including those in Health, Pharma & Biotech, that require patent protection for their innovations.

MAP-Health (Villgro)

Villgro's MAP-Health (Market Access Partnerships) program supports social enterprises within the Indian healthcare sector. Villgro, operating as India's oldest and largest social enterprise incubator, provides a platform for scaling solutions that address societal needs.

The program accelerates market entry and expansion for social enterprises. It offers strategic interventions and guidance, leveraging Villgro's experience in impact investing. MAP-Health supports market-ready innovations within healthcare, making it suitable for Health, Pharma & Biotech startups with a social impact focus. Funding amounts vary based on the enterprise's specific needs.

BIRAC Product Commercialization Program (PCP) Fund (BIRAC)

The Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Enterprise under the Department of Biotechnology (DBT), has established the BIRAC Product Commercialization Program (PCP) Fund. This initiative addresses a funding gap in the biotechnology innovation ecosystem, supporting product commercialization beyond the pre-commercialization stage. The deadline for this program is December 31, 2026.

The PCP Fund assists Indian biotechnology startups whose products or technologies have advanced through development and validation. It covers financial requirements for market preparation, pilot deployments, market validation, and large-scale commercialization. This program is specifically designed for Health, Pharma & Biotech innovations ready for market launch. Funding amounts vary.

SOSV Deep Tech Accelerator Program (SOSV)

SOSV, a global venture capital firm, provides pre-seed and early-stage investment to deep technology startups through its SOSV Deep Tech Accelerator Program. Initially known for its IndieBio program in San Francisco and New York City, these locations are now SOSV SF and SOSV NY, reflecting a broadened focus beyond pure biology to encompass the entire deep tech spectrum.

The program supports deep tech areas including AI, energy, materials, chemistry, plasma, and physics, alongside biology. It provides up to ₹4,56,50,000 for startups. Health, Pharma & Biotech startups leveraging advanced biological or other deep technologies are eligible to apply.

EthAum Zero BS Healthcare Revenue Scaler Program (EthAum Venture Partners)

The EthAum Zero BS Healthcare Revenue Scaler Program is a 16-week hybrid accelerator designed by EthAum Venture Partners. Its aim is to transform post-prototype healthcare and medical AI startups into revenue-generating, investment-ready enterprises. The program uses EthAum's global healthcare ecosystem to provide necessary tools, connections, and support for rapid scaling.

Participants gain access to enterprise customers, hospital pilot opportunities, strategic partnerships, and an investor network across key markets. The program provides up to ₹16,60,00,000. It is suitable for Health, Pharma & Biotech startups with a working prototype, particularly those in healthcare and medical AI seeking to scale revenue and prepare for investment.

D.E.S.I.G.N. for BioE3 Challenge (Department of Biotechnology (DBT))

The D.E.S.I.G.N. for BioE3 Challenge is a government initiative under India's BioE3 policy framework, driven by the Department of Biotechnology (DBT), BIRAC, and BRIC-ILS. It aims to inspire innovative, sustainable, and scalable biotechnological solutions from young students and researchers across India, with monthly submissions open for 20 days each month until October 2026.

Round 1 awards a cash appreciation grant of INR 1 lakh to the top 10 concept proposal winners monthly, with access to mentorship from DBT-BIRAC and various incubation facilities. Health, Pharma & Biotech concepts are directly aligned with this challenge's focus on biotechnology for economy, environment, and employment. The final deadline for the overall challenge is October 31, 2026, with rolling monthly submissions.

Indian Innovation Icons 2027 (Marico Innovation Foundation)

The Marico Innovation Foundation's Indian Innovation Icons 2027 is a biennial program supporting founders and innovators who address real-world challenges. This 11th edition offers strategic mentorship, investor access, business connections, and national visibility through a strong ecosystem of support.

This initiative welcomes applications from both for-profit businesses and not-for-profit organizations with groundbreaking innovations. Health, Pharma & Biotech startups with impactful solutions can benefit from the business connections and national visibility offered. Funding amounts vary.

Electropreneur Park OCP 3.0 Delhi (Electropreneur Park)

The Electropreneur Park OCP 3.0 Delhi Open Challenge Program by Electropreneur Park identifies and supports aspiring and early-stage tech entrepreneurs and innovators in the Electronics System Design & Manufacturing (ESDM) domain. It acts as a platform for these entrepreneurs, facilitating success through strategic networking, seed funding, expert mentoring, and support for training, marketing, and patenting activities. The deadline for this program is October 6, 2026.

Participants gain access to Electropreneur Park's Centers of Excellence (CoE) labs, specialized tools, and advanced incubation facilities. Health, Pharma & Biotech startups creating electronic devices, diagnostic equipment, or other hardware solutions within the ESDM sector would find this program relevant. Funding amounts vary.

Before Applying

Eligibility requirements vary across the programs. For instance, the Patent Reimbursement Incentives are specific to startups incubated and registered with the Karnataka Startup Cell. The EthAum Zero BS Healthcare Revenue Scaler Program targets post-prototype healthcare and medical AI startups, indicating a requirement for a developed product. Startups focusing on electronic devices within Health, Pharma & Biotech might consider Electropreneur Park OCP 3.0.

Several programs have specific deadlines or application structures. The BIRAC Product Commercialization Program (PCP) Fund closes on December 31, 2026, while the D.E.S.I.G.N. for BioE3 Challenge has rolling monthly submissions until October 31, 2026, and Electropreneur Park OCP 3.0 Delhi has an upcoming deadline of October 6, 2026. Programs like MAP-Health, SOSV Deep Tech Accelerator, EthAum Zero BS Healthcare Revenue Scaler, and Indian Innovation Icons 2027 accept applications on a rolling basis, allowing more flexibility for founders.